KMTS (Kestra Medical Technologies) Beginning Cash Position: $175.76 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KMTS Kestra Medical Technologies Ltd KMTS
10 GF Score
Price $24.24
! 4 Warning Signs
View Full Analysis

What is Kestra Medical Technologies Beginning Cash Position?

Kestra Medical Technologies KMTS -2.34% 10 Beginning Cash Position is $175.76 Mil as of Jan. 2026. GuruFocus rates KMTS with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Kestra Medical Technologies's Beginning Cash Position for the quarter that ended in Jan. 2026 was $175.76 Mil.

Kestra Medical Technologies's quarterly Beginning Cash Position declined from Jul. 2025 ($237.93 Mil) to Oct. 2025 ($201.55 Mil) and declined from Oct. 2025 ($201.55 Mil) to Jan. 2026 ($175.76 Mil).

Kestra Medical Technologies's annual Beginning Cash Position declined from Apr. 2021 ($6.27 Mil) to Apr. 2023 ($4.32 Mil) but then increased from Apr. 2023 ($4.32 Mil) to Apr. 2024 ($15.32 Mil).

Kestra Medical Technologies Beginning Cash Position Related Terms

Kestra Medical Technologies Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Kestra Medical Technologies's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kestra Medical Technologies Beginning Cash Position Chart

Kestra Medical Technologies Annual Data
Trend Apr20 Apr21 Apr23 Apr24
Beginning Cash Position
6.55 6.27 4.32 15.32

Kestra Medical Technologies Quarterly Data
Apr20 Jul20 Apr21 Jul21 Apr23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.25 54.69 237.93 201.55 175.76
KMTS
10GF Score
Kestra Medical Technologies Ltd KMTS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kestra Medical Technologies Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $175.76 Mil mean?
Kestra Medical Technologies (KMTS) has a Beginning Cash Position of $175.76 Mil as of Jan. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Kestra Medical Technologies and its competitors.
Is Kestra Medical Technologies' Beginning Cash Position too high?
Kestra Medical Technologies' current Beginning Cash Position is $175.76 Mil. Overall, Kestra Medical Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Beginning Cash Position compare to ATRC and STAA?
Kestra Medical Technologies' Beginning Cash Position of $175.76 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Kestra Medical Technologies and its competitors. Kestra Medical Technologies's current Beginning Cash Position is $175.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Beginning Cash Position of $175.76 Mil. The current Beginning Cash Position is $175.76 Mil. Kestra Medical Technologies' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Beginning Cash Position is $175.76 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kestra Medical Technologies Business Description

Address 3933 Lake Washington Boulevard NE, Suite 200, Kirkland, WA, USA, 98033
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
10GF Score

Get the complete analysis for KMTS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.24
Price